Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 1/20 | 0.72 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.72 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.72 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.59 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.59 |
| ▸ | ESR2 | Q92731 | 6/20 | 0.57 |
| ▸ | ESR1 | P03372 | 5/20 | 0.57 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.57 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.55 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.48 |
| ▸ | ERN1 | O75460 | 1/20 | 0.46 |
| ▸ | MIF | P14174 | 1/20 | 0.46 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30335758 | 1.00 | HDAC4 (0.72) | HDAC4HDAC2HDAC8HSD17B1HSD17B2 | |
| SCHEMBL28061095 | 0.94 | HDAC4 (0.66) | HDAC4HDAC2HDAC8HSD17B1HSD17B2 | |
| SCHEMBL19211556 | 0.90 | HDAC4 (0.66) | HDAC4HDAC2HDAC8HSD17B1HSD17B2 | |
| SCHEMBL20531408 | 0.87 | HDAC4 (0.62) | HDAC4HDAC2HDAC8HSD17B1HSD17B2 | |
| SCHEMBL10934707 | 0.85 | HDAC4 (0.60) | HDAC4HDAC2HDAC8HSD17B1HSD17B2 | |
| SCHEMBL17500108 | 0.85 | ESR2 (0.61) | HDAC4HDAC2HDAC8HSD17B1HSD17B2 | |
| SCHEMBL14327755 | 0.85 | HDAC4 (0.55) | HDAC4HDAC2HDAC8HSD17B1HSD17B2 | |
| SCHEMBL26502525 | 0.84 | HDAC4 (0.63) | HDAC4HDAC2HDAC8HSD17B1HSD17B2 | |
| SCHEMBL30491158 | 0.84 | GSTP1 (0.70) | HDAC4HDAC2HDAC8HSD17B1HSD17B2 | |
| SCHEMBL28508645 | 0.84 | GSTP1 (0.70) | HDAC4HDAC2HDAC8HSD17B1HSD17B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113461504-B | Method for preparing macrocyclic ketone from epoxide | 中国天辰工程有限公司 | 2023-04-21 | — | — | CN | disclosed |
| CN-105142605-B | 1, 2-alkane polyol-containing composition | 大阪有机化学工业株式会社 | 2018-06-08 | — | — | CN | disclosed |
| EP-2251316-B1 | METHOD FOR PRODUCING OPTICALLY ACTIVE ESTER AND METHOD FOR PRODUCING OPTICALLY ACTIVE CARBOXYLIC ACID | TOKYO UNIV OF SCIENCE EDUCATIONAL FOUNDATION ADMINISTRATIVE ORGANIZATION (JP) | 2018-02-21 | — | — | EP | disclosed |
| US-9795549-B2 | 1,2-alkane polyol-containing composition | OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (JP) | 2017-10-24 | — | — | US | disclosed |
| US-20160045414-A1 | 1,2-ALKANE POLYOL-CONTAINING COMPOSITION | OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (JP) | 2016-02-18 | — | — | US | disclosed |
| EP-2985017-A1 | 1,2-ALKANE POLYOL-CONTAINING COMPOSITION | Osaka Organic Chemical Ind., Ltd. (JP) | 2016-02-17 | — | — | EP | disclosed |
| CN-105142605-A | 1, 2-alkane polyol-containing composition | OSAKA ORGANIC CHEM IND | 2015-12-09 | — | — | CN | disclosed |
| US-8115008-B2 | Method for producing optically active ester and method for producing optically active carboxylic acid | TOKYO UNIVERSITY OF SCIENCE EDUCATION FOUNDATION ADMINISTRATIVE ORGANIZATION (JP) | 2012-02-14 | — | — | US | disclosed |
| EP-2251316-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE ESTER AND METHOD FOR PRODUCING OPTICALLY ACTIVE CARBOXYLIC ACID | Tokyo University Of Science Educational Foundation Administrative Organization (JP) | 2010-11-17 | — | — | EP | disclosed |
| US-20100234610-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE ESTER AND METHOD FOR PRODUCING OPTICALLY ACTIVE CARBOXYLIC ACID | TOKYO UNIVERSITY OF SCIENCE EDUCATIONAL FOUNDATION ADMINISTRATIVE ORGANIZATION (JP) | 2010-09-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100234610-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE ESTER AND METHOD FOR PRODUCING OPTICALLY ACTIVE CARBOXYLIC ACID | ACADM, ADH5, ALDH7A1 | HDAC4 1041/4885HDAC2 2928/4885HDAC8 642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.